On 26-27 March, MARC SE-Africa took part in a two-day East African Community (EAC) Regional Coordination Workshop for National Malaria Control Programme (NMCP) managers and partners in Entebbe, Uganda.

On 5 March, the MAGIC and Malawi Liverpool Wellcome Programme teams met with the Malawi National Malaria Programme Malaria Case Management Technical Working Group to agree on malaria treatment guidelines that will now be launched as part of the Malawi-specific MAGICapp.

On 26 February 2026, the Southern African Development Community (SADC) Ministers of Health endorsed the 2025 SADC Malaria Report, a crucial annual brief on the state of the fight against malaria in the region. For the first time, the document includes a dedicated section on antimalarial drug resistance, highlighting the urgent need for decisive action to protect the effectiveness of current malaria treatments.

MARC SE-Africa joins the malaria and global health communities in mourning the passing of Professor Sir Nick White, who dedicated his life to reducing the burden of malaria and other poverty related infectious diseases. Millions of lives have been saved by these efforts.

From 26 to 30 January 2026, MARC SE-Africa hosted a fast-paced, five-day antimalarial resistance writing workshop in Cape Town, set against the scenic backdrop of Chapman’s Peak and Noordhoek beach.

On 11 November 2025, MARC SE-Africa and the Worldwide Antimalarial Resistance Network co-hosted a symposium at the American Society of Tropical Medicine and Hygiene’s annual meeting and presented some of the latest project milestones.

On 15 September, the RBM Partnership to End Malaria, MARC SE-Africa, and the Malawi Liverpool Wellcome Research Programme policy unit convened a policy dialogue on tackling antimalarial drug resistance in the lead-up to the 14th RBM Case Management Working Group meeting in Abidjan, Côte d’Ivoire.

On 1 September 2025, MARC SE-Africa hosted the final webinar in the antimalarial drug resistance series, this time exploring the role of pharmaceutical and regulatory bodies in addressing drug-resistant malaria.

Join the webinar where industry representatives will reflect on the role of pharmaceutical and regulatory bodies in addressing the growing threat of antimalarial drug resistance, explore the gaps and challenges to a coordinated response, and recommend actionable strategies to overcome them.

On 23 July 2025, malaria researchers and practitioners joined the MARC SE-Africa webinar to explore open-access tools developed by MARC SE-Africa and WWARN. These platforms aggregate malaria-related data and are freely available to support decision-making by national malaria control programme managers and other stakeholders.

Between 29 and 31 July, malaria researchers and malaria elimination program managers came together at the 10th Southern Africa Malaria Research Conference in Pretoria to shape the agenda for eliminating malaria. MARC SE-Africa was represented by Prof Karen Barnes and Dr Jonathan Gwasupika, who spoke about the consortium’s work in tackling antimalarial drug resistance.

Join the webinar to learn about the MARC SE-Africa antimalarial dashboard and how it aggregates and visualises real-time data on antimalarial resistance, treatment efficacy, and molecular markers.

Dr Stephanie Van Wyk explains why sharing malaria data matters, how researchers can help by sharing their findings without delay, and how digital tools are making this information more accessible to those who drive actionable change in the fight against malaria.

Key stakeholders addressing drug-resistant malaria in Africa participated in the MARC SE-Africa webinar on strengthening regional collaboration to tackle this urgent and growing issue. They learned how the Regional detailed action plan for responding to antimalarial drug resistance in East Africa was created and how this experience can inform similar work in Southern Africa.

Join the webinar to learn about the consensus-building process in East Africa that resulted in a regional action plan, and about how this example can be used for similar action elsewhere.

Malaria researchers, representatives of national malaria programmes, ministries of health and other malaria practitioners joined a MARC SE-Africa webinar, looking to learn more about the current state of antimalarial drug resistance in Southern and East Africa and ways to address it.

On 6 and 7 May 2025, MARC SE-Africa representatives joined the final in-person meeting for the Development of Triple Artemisinin-based Combination Therapies (DeTACT) project in Zanzibar, strengthening ties between research projects tackling drug-resistant malaria.

On 9 May 2025, during the 25th Ordinary Meeting of the East African Community (EAC) Sectoral Council of Ministers of Health, the region’s ministries of health officially endorsed the Regional Detailed Action Plan for Responding to Antimalarial Drug Resistance in East Africa.

Renowned experts on the topic of antimalarial resistance in Southern and Eastern Africa – Prof Karen Barnes (University of Cape Town) and Dr Aline Uwimana (University of Rwanda) – will present the current state of antimalarial resistance in the region and how the work of MARC SE-Africa has informed and supported antimalarial policy in Rwanda.

In celebration of World Malaria Day, MARC SE-Africa held an online writing workshop for malaria researchers on 23 April, offering participants dedicated writing time, topical workshops and a platform for collaboration.